Document is current

Article History

Received: 24 July 2024

Accepted: 15 November 2024

First Online: 9 December 2024

Declarations

:

: Not applicable.

: Not applicable.

: Dr. Gina Lacuesta has received consulting fees, honoraria and research funding from Takeda, AstraZeneca and Novartis; consulting fees and honoraria from CSL Behring, GSK, Sanofi, Pfizer and Amgen; and consulting fees from BioCryst. Dr. Ellie Tsai has received honoraria and consulting fees from ALK, Astra Zeneca, ICI Medical Communications, Novartis and Sanofi; honoraria from Covis Pharma, CPD Network, GSK, Medexus, Miravo Healthcare and Valeo Pharma; and consulting fees from Bausch Health. Dr. Stephen D. Betschel has received consulting fees, honoraria, and research funding from Astria, Canadian Blood Services, CSL Behring, Green Cross, Grifols, Ionis Pharmaceuticals, Kalvista Novartis, Octapharma, Pharvaris, Sanofi, Takeda, and WSIB. Dr. Harold Kim has received consulting fees from and/or has participated in speakers’ bureau and/or advisory boards for ALK, AstraZeneca, Bausch Health, CSL Behring, GSK, Miravo, Novartis, Pediapharm, Pfizer, Sanofi, Shire, Takeda and Valeo.